The PVOH device: Our first stop on the path to small and very small physical embodiments of the PV[O]H algorithm

David Rice, Jeffrey Bebernes, Sheryl Bebernes, John Fayos, Jonathan Cormier, Michael Houk, Howard Ammenheuser, Seth Fillioe, Charles M. Peterson, J. Chaiken

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Several years ago we proposed a new algorithm, PV[O]H, to allow noninvasive in vitro and in vivo spectroscopic analysis of mildly turbid i.e. optically thin or dilute samples that can be considered two phase systems such as plasma and red blood cells (RBCs). The goal was to provide a method for measuring the volume fraction of the sample for each of the two phases noninvasively without physical sampling or labeling. The first application of this approach was to calculate the volume fractions of plasma and RBCs for blood in the peripheral vasculature of skin, to calculate the hematocrit (Hct) of the blood as an early indicator of blood loss. Having validated PV[O]H in completely defined in vitro systems and then for bacterial cultures in various media, we began to envision potential uses for PV[O]H in medicine and biotech applications. Every potential application presents special requirements but nearly all require the embodiment to be physically small and light and have a minimum power footprint. Some applications require retaining the capacity to perform Raman spectroscopy while utilizing PV[O]H and others do not. We describe our first attempt to design and fabricate a small device that can implement PV[O]H without Raman capability. Among many potential uses, we intend PVOH for medical uses involving indications of 1) potential undetected internal bleeding, 2) hematocrit variation during dialysis and 3) infection and inflammation in spinal cord injury. PV[O]H also has potential utility in wellness, exercise science and physiological monitoring of small vessel plasma and red cell volumes continuously over time.

Original languageEnglish (US)
Title of host publicationPhotonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2020
EditorsTianhong Dai, Jurgen Popp, Mei X. Wu
PublisherSPIE
ISBN (Electronic)9781510632097
DOIs
StatePublished - Jan 1 2020
EventPhotonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2020 - San Francisco, United States
Duration: Feb 3 2020Feb 4 2020

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume11223
ISSN (Print)1605-7422

Conference

ConferencePhotonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2020
CountryUnited States
CitySan Francisco
Period2/3/202/4/20

Keywords

  • Dialysis
  • Hematocrit
  • Hemorrhage
  • In vivo
  • Noninvasive
  • Physiological monitoring
  • PV[O]H
  • Spinal cord injury
  • Vascular volume
  • Wearable

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Atomic and Molecular Physics, and Optics
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'The PVOH device: Our first stop on the path to small and very small physical embodiments of the PV[O]H algorithm'. Together they form a unique fingerprint.

  • Cite this

    Rice, D., Bebernes, J., Bebernes, S., Fayos, J., Cormier, J., Houk, M., Ammenheuser, H., Fillioe, S., Peterson, C. M., & Chaiken, J. (2020). The PVOH device: Our first stop on the path to small and very small physical embodiments of the PV[O]H algorithm. In T. Dai, J. Popp, & M. X. Wu (Eds.), Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2020 [1122309] (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 11223). SPIE. https://doi.org/10.1117/12.2546515